Medirom Non Currrent Assets Other vs Other Current Liab Analysis
| MRM Stock | USD 5.93 0.12 2.07% |
Medirom Healthcare financial indicator trend analysis is infinitely more than just investigating Medirom Healthcare recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Medirom Healthcare is a good investment. Please check the relationship between Medirom Healthcare Non Currrent Assets Other and its Other Current Liab accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medirom Healthcare Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area.
Non Currrent Assets Other vs Other Current Liab
Non Currrent Assets Other vs Other Current Liab Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Medirom Healthcare Non Currrent Assets Other account and Other Current Liab. At this time, the significance of the direction appears to have pay attention.
The correlation between Medirom Healthcare's Non Currrent Assets Other and Other Current Liab is -0.88. Overlapping area represents the amount of variation of Non Currrent Assets Other that can explain the historical movement of Other Current Liab in the same time period over historical financial statements of Medirom Healthcare Technologies, assuming nothing else is changed. The correlation between historical values of Medirom Healthcare's Non Currrent Assets Other and Other Current Liab is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Non Currrent Assets Other of Medirom Healthcare Technologies are associated (or correlated) with its Other Current Liab. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Other Current Liab has no effect on the direction of Non Currrent Assets Other i.e., Medirom Healthcare's Non Currrent Assets Other and Other Current Liab go up and down completely randomly.
Correlation Coefficient | -0.88 |
| Relationship Direction | Negative |
| Relationship Strength | Significant |
Non Currrent Assets Other
Assets that are not physical or tangible, expected to provide value for more than one year, and not easily converted into cash, such as long-term investments or patents.Other Current Liab
Most indicators from Medirom Healthcare's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Medirom Healthcare current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medirom Healthcare Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. At this time, Medirom Healthcare's Sales General And Administrative To Revenue is very stable compared to the past year. As of the 17th of May 2024, Enterprise Value Over EBITDA is likely to grow to 27.41, while Tax Provision is likely to drop about 33.7 M.
| 2020 | 2021 | 2023 | 2024 (projected) | Gross Profit | 317.7M | 1.4B | 1.6B | 1.1B | Total Revenue | 1.4B | 5.4B | 6.2B | 4.3B |
Medirom Healthcare fundamental ratios Correlations
Click cells to compare fundamentals
Medirom Healthcare Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Medirom Healthcare fundamental ratios Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Long Term Debt | 150.5M | 668.4M | 746.6M | 1.1B | 1.3B | 672.8M | |
| Capital Lease Obligations | 1.8B | 1.7B | 1.9B | 2.0B | 1.8B | 1.5B | |
| Net Invested Capital | 1.1B | 1.3B | 700.5M | 1.2B | 1.4B | 1.1B | |
| Property Plant And Equipment Gross | 2.0B | 183.1M | 2.4B | 2.6B | 3.0B | 2.1B | |
| Short Long Term Debt | 371.6M | 221.1M | 162.3M | 99.2M | 89.3M | 84.8M | |
| Non Current Liabilities Other | 5.6M | 348.4M | 25.2M | 335.0M | 385.2M | 404.5M | |
| Net Working Capital | (884.0M) | 428.3M | (1.8B) | (1.3B) | (1.2B) | (1.2B) |
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Medirom Healthcare using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Medirom Healthcare Technologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Complementary Tools for Medirom Stock analysis
When running Medirom Healthcare's price analysis, check to measure Medirom Healthcare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medirom Healthcare is operating at the current time. Most of Medirom Healthcare's value examination focuses on studying past and present price action to predict the probability of Medirom Healthcare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medirom Healthcare's price. Additionally, you may evaluate how the addition of Medirom Healthcare to your portfolios can decrease your overall portfolio volatility.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |
Is Medirom Healthcare's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Medirom Healthcare. If investors know Medirom will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Medirom Healthcare listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.05) | Revenue Per Share 1.4 K | Quarterly Revenue Growth 0.03 | Return On Assets (0.01) | Return On Equity (7.00) |
The market value of Medirom Healthcare is measured differently than its book value, which is the value of Medirom that is recorded on the company's balance sheet. Investors also form their own opinion of Medirom Healthcare's value that differs from its market value or its book value, called intrinsic value, which is Medirom Healthcare's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Medirom Healthcare's market value can be influenced by many factors that don't directly affect Medirom Healthcare's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Medirom Healthcare's value and its price as these two are different measures arrived at by different means. Investors typically determine if Medirom Healthcare is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Medirom Healthcare's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.